Determinants of female reproductive senescence: Differential roles for the ovary and the neuroendocrine axis

Erkan Buyuk, Edward Nejat, Genevieve Neal-Perry

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Aging in women is a complex process that begins with the transition into reproductive senescence and evolves to impact not just women's procreative potential but also multiple health-related parameters including longevity. Although somatic aging is an equal opportunity nemesis, certain disease states correlate highly with ovarian failure and the menopause, such as osteoporosis, diabetes, cardiovascular disease, and compromised cognitive function. Epidemiological studies suggest that a delayed natural menopause confers longevity and decelerates the appearance of many of the debilitating morbidities associated with the menopause. However, recent randomized clinical trials assessing the benefits of menopausal hormone therapy during the postmenopause clearly suggest that attenuation of the negative consequences of reproductive aging involves much more than a simple add back of ovarian steroids in the postmenopause. Conflicts between observations in epidemiological studies and in randomized clinical trials give good reason for continued innovative research focused on identifying the mechanisms that bring about the transition from peak reproductive potential to female reproductive quiescence. This article provides a brief update on our current understanding of the physiological and cellular mechanisms that precipitate and/or commit women to transit into reproductive senescence.

Original languageEnglish (US)
Pages (from-to)370-379
Number of pages10
JournalSeminars in Reproductive Medicine
Volume28
Issue number5
DOIs
StatePublished - 2010

Fingerprint

Menopause
Postmenopause
Ovary
Epidemiologic Studies
Randomized Controlled Trials
Cognition
Osteoporosis
Cardiovascular Diseases
Steroids
Hormones
Morbidity
Health
Research
Therapeutics

Keywords

  • Female
  • neuroendocrine
  • ovary
  • reproduction
  • senescence

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Determinants of female reproductive senescence : Differential roles for the ovary and the neuroendocrine axis. / Buyuk, Erkan; Nejat, Edward; Neal-Perry, Genevieve.

In: Seminars in Reproductive Medicine, Vol. 28, No. 5, 2010, p. 370-379.

Research output: Contribution to journalArticle

Buyuk, Erkan ; Nejat, Edward ; Neal-Perry, Genevieve. / Determinants of female reproductive senescence : Differential roles for the ovary and the neuroendocrine axis. In: Seminars in Reproductive Medicine. 2010 ; Vol. 28, No. 5. pp. 370-379.
@article{109b0acb84fd4743a8549e43c9049cb5,
title = "Determinants of female reproductive senescence: Differential roles for the ovary and the neuroendocrine axis",
abstract = "Aging in women is a complex process that begins with the transition into reproductive senescence and evolves to impact not just women's procreative potential but also multiple health-related parameters including longevity. Although somatic aging is an equal opportunity nemesis, certain disease states correlate highly with ovarian failure and the menopause, such as osteoporosis, diabetes, cardiovascular disease, and compromised cognitive function. Epidemiological studies suggest that a delayed natural menopause confers longevity and decelerates the appearance of many of the debilitating morbidities associated with the menopause. However, recent randomized clinical trials assessing the benefits of menopausal hormone therapy during the postmenopause clearly suggest that attenuation of the negative consequences of reproductive aging involves much more than a simple add back of ovarian steroids in the postmenopause. Conflicts between observations in epidemiological studies and in randomized clinical trials give good reason for continued innovative research focused on identifying the mechanisms that bring about the transition from peak reproductive potential to female reproductive quiescence. This article provides a brief update on our current understanding of the physiological and cellular mechanisms that precipitate and/or commit women to transit into reproductive senescence.",
keywords = "Female, neuroendocrine, ovary, reproduction, senescence",
author = "Erkan Buyuk and Edward Nejat and Genevieve Neal-Perry",
year = "2010",
doi = "10.1055/s-0030-1262896",
language = "English (US)",
volume = "28",
pages = "370--379",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "5",

}

TY - JOUR

T1 - Determinants of female reproductive senescence

T2 - Differential roles for the ovary and the neuroendocrine axis

AU - Buyuk, Erkan

AU - Nejat, Edward

AU - Neal-Perry, Genevieve

PY - 2010

Y1 - 2010

N2 - Aging in women is a complex process that begins with the transition into reproductive senescence and evolves to impact not just women's procreative potential but also multiple health-related parameters including longevity. Although somatic aging is an equal opportunity nemesis, certain disease states correlate highly with ovarian failure and the menopause, such as osteoporosis, diabetes, cardiovascular disease, and compromised cognitive function. Epidemiological studies suggest that a delayed natural menopause confers longevity and decelerates the appearance of many of the debilitating morbidities associated with the menopause. However, recent randomized clinical trials assessing the benefits of menopausal hormone therapy during the postmenopause clearly suggest that attenuation of the negative consequences of reproductive aging involves much more than a simple add back of ovarian steroids in the postmenopause. Conflicts between observations in epidemiological studies and in randomized clinical trials give good reason for continued innovative research focused on identifying the mechanisms that bring about the transition from peak reproductive potential to female reproductive quiescence. This article provides a brief update on our current understanding of the physiological and cellular mechanisms that precipitate and/or commit women to transit into reproductive senescence.

AB - Aging in women is a complex process that begins with the transition into reproductive senescence and evolves to impact not just women's procreative potential but also multiple health-related parameters including longevity. Although somatic aging is an equal opportunity nemesis, certain disease states correlate highly with ovarian failure and the menopause, such as osteoporosis, diabetes, cardiovascular disease, and compromised cognitive function. Epidemiological studies suggest that a delayed natural menopause confers longevity and decelerates the appearance of many of the debilitating morbidities associated with the menopause. However, recent randomized clinical trials assessing the benefits of menopausal hormone therapy during the postmenopause clearly suggest that attenuation of the negative consequences of reproductive aging involves much more than a simple add back of ovarian steroids in the postmenopause. Conflicts between observations in epidemiological studies and in randomized clinical trials give good reason for continued innovative research focused on identifying the mechanisms that bring about the transition from peak reproductive potential to female reproductive quiescence. This article provides a brief update on our current understanding of the physiological and cellular mechanisms that precipitate and/or commit women to transit into reproductive senescence.

KW - Female

KW - neuroendocrine

KW - ovary

KW - reproduction

KW - senescence

UR - http://www.scopus.com/inward/record.url?scp=77956954733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956954733&partnerID=8YFLogxK

U2 - 10.1055/s-0030-1262896

DO - 10.1055/s-0030-1262896

M3 - Article

C2 - 20845237

AN - SCOPUS:77956954733

VL - 28

SP - 370

EP - 379

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 5

ER -